These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17666055)

  • 1. Catheter ablation of atrial fibrillation: is the burn worth the buck?
    Estes NA
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):914-6. PubMed ID: 17666055
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost comparison of catheter ablation and medical therapy in atrial fibrillation.
    Khaykin Y; Morillo CA; Skanes AC; McCracken A; Humphries K; Kerr CR
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):907-13. PubMed ID: 17666065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: rarely a good value.
    Majithia A; Reynolds MR
    Europace; 2015 Jan; 17(1):5-6. PubMed ID: 25552671
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lone atrial fibrillation--relevance for medical underwriting].
    Filzmaier K
    Versicherungsmedizin; 2013 Sep; 65(3):128-31. PubMed ID: 24137892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.
    Khaykin Y; Wang X; Natale A; Wazni OM; Skanes AC; Humphries KH; Kerr CR; Verma A; Morillo CA
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):7-12. PubMed ID: 18803564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summaries for patients. Cost-effectiveness of rate control vs. rhythm control for patients with atrial fibrillation.
    Ann Intern Med; 2004 Nov; 141(9):I20. PubMed ID: 15520416
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.
    Chew DS; Loring Z; Anand J; Fudim M; Lowenstern A; Rymer JA; Weimer KED; Atwater BD; DeVore AD; Exner DV; Noseworthy PA; Yancy CW; Mark DB; Piccini JP
    Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007094. PubMed ID: 33280436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
    Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
    J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
    Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
    Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total costs and atrial fibrillation ablation success or failure in Medicare-aged patients in the United States.
    Kim MH; Lin J; Kreilick C; Foltz Boklage SH
    Adv Ther; 2010 Sep; 27(9):600-12. PubMed ID: 20700678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation.
    Nault I; Miyazaki S; Forclaz A; Wright M; Jadidi A; Jaïs P; Hocini M; Haïssaguerre M
    Eur Heart J; 2010 May; 31(9):1046-54. PubMed ID: 20332181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of atrial fibrillation: invasive vs non-invasive management in 2012.
    Khaykin Y; Shamiss Y
    Curr Cardiol Rev; 2012 Nov; 8(4):368-73. PubMed ID: 22920478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of atrial fibrillation therapy.
    Heim SW
    J Fam Pract; 1998 Nov; 47(5):334-5. PubMed ID: 9834762
    [No Abstract]   [Full Text] [Related]  

  • 14. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of atrial fibrillation catheter ablation.
    Andrikopoulos G; Tzeis S; Maniadakis N; Mavrakis HE; Vardas PE
    Europace; 2009 Feb; 11(2):147-51. PubMed ID: 19098290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation].
    Tilz RR; Kuck KH
    Herz; 2015 Feb; 40(1):7. PubMed ID: 25645236
    [No Abstract]   [Full Text] [Related]  

  • 17. Ablation to treat atrial fibrillation: beyond rhythm control.
    Zak J
    Crit Care Nurse; 2010 Dec; 30(6):68-79. PubMed ID: 21123234
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of rhythm versus rate control in atrial fibrillation.
    Marshall DA; Levy AR; Vidaillet H; Fenwick E; Slee A; Blackhouse G; Greene HL; Wyse DG; Nichol G; O'Brien BJ;
    Ann Intern Med; 2004 Nov; 141(9):653-61. PubMed ID: 15520421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany.
    McBride D; Mattenklotz AM; Willich SN; Brüggenjürgen B
    Value Health; 2009; 12(2):293-301. PubMed ID: 18657103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of focal impulse and rotor modulation guided ablation added to pulmonary vein isolation for atrial fibrillation.
    Baykaner T; Duff S; Hasegawa JT; Mafilios MS; Turakhia MP
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):526-536. PubMed ID: 29436112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.